sponsored by


Endsleigh offer competitive
Life Insurance policies

Calendar

«« Sep 2007 »»
S M T W T F S
           
1
2
3
4
5
6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30

Search Box


HealthCentral Top Site Award

IBS Tales Hope Award

LinkBlog

Crying Shame - a Priory Group survey about stigma and mental illness in Britain (pdf)

6 Golden Rules for Conquering Performance Anxiety by David Leisner

Freedom from Fear's On Target Summer/Fall 2007 newsletter - an anxiety & depression resource (PDF)

Switching between monoamine oxidase inhibitors (MAOIs) and SSRI or tricyclic antidepressants (.doc format)

  More

Contact

Mailing List

RSS Feeds








Translation

Disclaimer

All content within Anxiety Insights is provided for general information only, and should not be treated as a substitute for the medical advice of your doctor or other health care professional.

Anxiety Insights is not responsible or liable for any diagnosis made by a reader based on the content of this website.

Anxiety Insights is not liable for the contents of any external internet sites listed, nor does it endorse any commercial product or service mentioned or advised on any of the sites.

Always consult your doctor if you are in any way concerned about your health.

recommended links

Depression is Real's Down & Up Show
      Weekly audio-casts from the
      Depression Is Real Coalition


No Longer Lonely.com

"just don't smoke"


"Don't smoke, whatever you do, just don't smoke."
                        Yul Brynner

Hit Counter

Total: 845,813
since: 14 May 2006

Admin console

Log-In

My Blog    My Profile

Leave Message

Add as neighbors






Blogion.com

Blog Flux Directory



Blogarama - The Blogs Directory

blog search directory

BlogTagstic - Blog Directory

Find Blogs in the Blog Directory



LS Blogs

Top Health Sites





Health Blogs - Blog Top Sites

Bloggapedia - Find It!

Abstract: Triple uptake inhibitors: therapeutic potential in depression and beyond.

« H E » email
posted Sunday, 26 August 2007

Expert Opin Investig Drugs. 2007 Sep;16(9):1365-77.

Triple uptake inhibitors: therapeutic potential in depression and beyond.

Chen Z, Skolnick P.

DOV Pharmaceutical, Inc., Somerset, NJ 08873-4185, USA.

Drugs that interfere with the uptake and/or metabolism of biogenic amines have been used to treat depression for > 4 decades.

Early medications such as tricyclic antidepressants and monoamine oxidase inhibitors are effective but possess many side effects that limit their usefulness.

Selective serotonin reuptake inhibitors (SSRIs) or selective noradrenaline reuptake inhibitors (SNRIs) are the results of rational design to find drugs that are as effective as the tricyclic antidepressants, but with more selectivity towards a single monoamine transporter. The SSRI class of drugs, which includes fluoxetine, paroxetine and sertraline, were previously viewed as the agents of choice for treating major depression.

Recently, inhibitors of both serotonin and noradrenaline uptake ('dual uptake inhibitors'; SSRI/SNRI such as venlafaxine, duloxetine and milnacipran) have gained acceptance in the market.

However, neither the SSRIs nor the SSRI/SNRI are fully satisfactory due to a delayed onset of action, low rate of response and side effect that can affect compliance.

An important recent development has been the emergence of the triple uptake inhibitors (SSRI/SNRI/selective dopamine reuptake inhibitor), which inhibit the uptake of all three neurotransmitters that are most closely linked to depression: serotonin, noradrenaline and dopamine. Preclinical studies and clinical trials indicate that a drug inhibiting the uptake of all three of these neurotransmitters could produce a more rapid onset of action and possess greater efficacy than traditional antidepressants.

This review discusses the evolution of biogenic amine-based therapies, the emerging strategies involved in the design and synthesis of novel triple uptake inhibitors as antidepressants and the therapeutic potential of triple uptake inhibitors.

PMID: 17714023 [PubMed - in process]


(Text has been reformatted for clarity; Highlight added, Ed.)

Source...

tags:  

links: digg this    del.icio.us    technorati    reddit